Abstract: A dispensing container which incorporates an aerosolizable topical insulin preparation, at least one oral hypoglycemic agent, and indicia and instructions for their coordinated use as a single therapeutic regimen for the treatment of diabetes mellitus in a human, and a method for treating diabetes mellitus which employs such a device.

Abstract: A single dosage medication formulation has a beta-adrenergic blocker and a cholesterol lowering agent that is a statin combined in a single oral formulation for treatment of and reducing the risk of cardiovascular disease to enhance simplicity, cost reduction, convenience, and patient compliance with the use of these agents.

Abstract: A method and device for organizing, storing, instructing, and coordinating the combined use of topical therapeutic agents, including moisturizing agents, for the treatment of respiratory tract disorders.

Abstract: The production of sex steroids by the &Dgr;-5 steroidogenic pathway has been found to be under control of the adrenergic nervous system, and sex steroids produced by this pathway are diminished in individuals with adrenergically-blockaded conditions. This invention relates to diminishing the consequences of suppressed &Dgr;-5 pathway steroidogenesis in individuals with adrenergically blockaded conditions by the administration of compositions which raise the serum levels of sex steroids.

Abstract: A sinusitis treatment system having an oral dosage constituent, a topical nasal dosage constituent, indicia and instructions for administration of the oral dosage constituent and the topical nasal dosage constituent as an at least ten-day sinusitis treatment regimen.

Abstract: A prefilled, unifying dispensing container of at least two different medication dosage units comprising a regimen for the treatment of rhinitis, indicia for distinguishing the dosage units, and coordinating instructions. The medications may be contained in bottles, blister packages, or pouches. Medications include antihistamine and nasal decongestant. One dosage is for administration when sedation is not desired and the other is for administration when stimulation is not desired.

Abstract: Pharmaceutical dosage forms for oral administration of an antihistamine and a decongestant are disclosed. The dosage forms provide an antihistamine in an amount and formulation to exhibit antihistaminic activity in a human for greater than 22 hours; and a decongestant in an amount and formulation to exhibit stimulatory activity in a human for less than 16 hours. The formulation of the invention can be taken once per day to afford symptomatic relief of rhinitis while avoiding stimulation at night.

Abstract: A device and method for use in conjunction with exercise of about one hour or less which enhances convenience, and encourages compliance with a regimen of exercise beverages to accomplish preexercise hydration and postexercise hydration and muscle glycogen replenishment, and which includes a preexercise beverage formulation and a postexercise beverage formulation combined in a unified package with indicia and instructions. The preexercise beverage has a carbohydrate concentration of not more than about 9%, and the postexercise beverage has a carbohydrate concentration of at least about 13%.

Abstract: It is perceived that the newer antihistamines, which have been developed so as to be less sedating relative to the "first generation" antihistamines, possess diminished anticholinergic effects on rhinorrhea, compared to first-generation antihistamines. It is also perceived that no oral medicinal formulation is presently available for treatment of allergic rhinitis that provides both antihistaminic and anticholinergic actions and is unlikely to produce sedation. This invention provides such a formulation.

Abstract: An oral once-per-day single dosage unit for treating the symptoms of rhinitis expertly formulated with a nasal decongestant and antihistamine. Preferably, the antihistamine is non-sedating.

Abstract: An assemblage and system for drinking a plurality of potable and/or medicinal liquids simultaneously from discrete receptacles. The assemblage comprises a plurality of conduits joined together that convey isolated streams of the liquids from separate receptacles into the mouth. Preferably, the conduits are mechanically deformable along their axes of elongation. The conduits are joined by a catch, by binding, by molding the conduits as a single unit, by a joining structure, or by raveling. The system includes the assemblage and a number of joined receptacles.

Abstract: An assemblage for drinking a plurality of potable and/or medicinal liquids simultaneously from discrete receptacles while prevent contamination of one liquid by another. The assemblage comprises a plurality of conduits joined together that convey isolated streams of the liquids from separate receptacles into the mouth. Preferably, the conduits are mechanically deformable along their axes of elongation. The conduits are joined by a catch, by binding, by molding the conduits as a single unit, or by raveling. At least one conduit includes a check valve.

Abstract: An integrated package including two nutrient beverage formulations in discrete, sealed containers and instructions for use of the formulations in conjunction with a relatively short exercise session to enhance performance and reduce the adverse effects of the exercise. The formulations are compatibly designed for the needs of the different phases of exercise. The formulations are provided in either fully-constituted liquid form or as water-soluble concentrates. The formulations are combined in a unified package with indicia and instructions. The formulations include fluids, electrolytes, carbohydrates, and other optional agents including vitamin E, glycerol, alkaline salts, stimulants, creatine, specific amino acids, aspartates, phosphates, and pyruvate.

Abstract: A wetted, disposable wipe constructed by bonding a layer of absorbent material to one side of a barrier sheet that is impermeable to infectious agents and insoluble in dermatological fluids, filling a reservoir in the barrier with a dermatological fluid, and hermetically sealing the absorbent layer between the barrier and a cover. The peripheral edges of the absorbent layer are spaced inwardly from the peripheral edges of the barrier to provide a surrounding zone of the impermeable barrier alone. The absorbent layer bond to the barrier is resistant to degradation caused by exposure to the dermatological fluid. The cover is secured by an adhesive that is resistant to degradation caused by exposure to the dermatological fluid and that allows the cover to be manually peeled from the barrier. The reservoir holds the dermatological fluid temporarily to prevent vapors from the fluid from igniting during the barrier/cover sealing process.

Abstract: A method and device for organizing, storing, instructing, and coordinating the combined use of aerosol medications for the treatment of disorders including respiratory tract disorders for the purpose of reducing medication error and increasing therapeutic compliance.

Abstract: Power is supplied to a load from either a first power source or a second power source. A transfer switch determines which of the power sources provides the power to the load. A switch control detects a loss in the power provided by a first power source and signals the transfer switch to switch to a second power source. A small energy storage device provides power to the load, during the switch from the first power source to the second power source.

Abstract: An allergy treatment that combines graphical indicia and medicinal dosages in at least three logically related physical formats, according to at least three medically related clinical steps. The first physical format, in reference to Step 1, presents a plurality of categories of queries regarding allergenic substances and conditions. The second physical format, in reference to Step 2, presents a plurality of categories of actions regarding recommendations for allergy avoidance. The third physical format, in reference to Step 3, presents one or more categories of medicinal dosages in one or more logically related physical regions, which are accompanied by a set of instructions.

Abstract: A method and device for organizing, storing, instructing, and coordinating the combined use of aerosol and oral medications for the treatment of disorders including respiratory tract disorders for the purpose of reducing medication error and increasing therapeutic compliance.

Abstract: An assemblage and system for drinking a plurality of potable and/or medicinal liquids simultaneously from discrete receptacles. The assemblage comprises a plurality of conduits joined together that convey isolated streams of the liquids from separate receptacles into the mouth. The cross-sectional area of the conduits regulate the amount of each liquid reaching the mouth and may be dynamically controlled. Preferably, the conduits are mechanically deformable along their axes of elongation. Preferably, the conduits are joined together near the end of the conduits that enter the mouth. The conduits are joined by a catch, by binding, or by molding the conduits as a single unit. The system includes the assemblage and a number of isolated receptacles.

Abstract: Disclosed is an MR head, and the method of making the same, which has a pole/shield. In the preferred embodiment, the pole side of the pole/shield is constructed such that it has a length that is approximately equal to the length of the pole, and a shield side that is approximately the length of a shield. Through this construction, the MR element, which is disposed between the shield side and the shield, is fully shielded during a read operation. Additionally, the flux lines generated during a write operation approximate the length of the pole so that excessive fringing does not occur. As a result of the smaller flux lines generated between the pole and the pole side of the pole/shield, data may be more densely packed on the disk used in conjunction with the MR head.